The article focuses on the process of informed consent before cancer therapy as per the American Society of Clinical Oncology / ONS Chemotherapy Administration Safety standards. It discusses how patients have to give their approval for treatment plan and testing for a clinical trail enrollment, how the caregivers or patients should understand the risks and change in the plan.